SinoPharm HKG:1099 – Hong Kong Blue Chip stock

SinoPharm (HKG:1099)

Hong Kong Blue Chip Stock • Sector: Medicine

Last updated: February 28, 2026
Next ex-dividend date: N/A

The company distributes medicine to hospitals, pharmacies, and clinics. They also run pharmacy stores, distribute medical devices and laboratory supplies, make chemical reagents, and sell pharmaceutical products.

Stock Value Score

This score indicates whether the stock currently appears undervalued, fairly priced, or expensive,
based on key valuation metrics such as earnings, book value, and cash flow.

P/E ratio 8.70
P/B ratio 0.75
EPS 2.47
Beta 0.51

Beta above 1 suggests higher volatility. Below 1 suggests more stability relative to the market.

So what’s the takeaway?
Based on current valuation metrics, the stock appears .
Future changes in earnings, cash flow, or price could materially shift this assessment.

Champion Members see the full 3-Pillar scorecard:
Dividend Growth,
Dividend Safety,
Stock Value.


Learn more about Champion Membership

You need to be logged in to view the rest of the content. Please .